(INSM) Insmed - Performance 183.9% in 12m
Compare INSM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
46.79%
#10 in Group
Rel. Strength
98.35%
#133 in Universe
Total Return 12m
183.86%
#6 in Group
Total Return 5y
192.20%
#11 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -5.73%
(?) Percentile in Group
12m Total Return: INSM (183.9%) vs XBI (-5.4%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
| HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
| AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
| LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
| ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
| BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: INSM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for INSM
| Total Return (including Dividends) | INSM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.89% | 5.55% | -0.45% |
| 3 Months | -6.73% | -9.75% | -6.29% |
| 12 Months | 183.86% | -5.39% | 13.04% |
| 5 Years | 192.20% | -13.20% | 111.82% |
| Trend Score (consistency of price movement) | INSM | XBI | S&P 500 |
| 1 Month | 23.8% | 70% | 47.5% |
| 3 Months | -80.0% | -88.1% | -87.3% |
| 12 Months | 43.6% | -44.4% | 54.3% |
| 5 Years | 19.6% | -53.6% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #125 | -4.42% | 1.34% |
| 3 Month | #72 | 3.35% | -0.46% |
| 12 Month | #6 | 200% | 151% |
| 5 Years | #11 | 237% | 38.0% |
FAQs
Does INSM Insmed outperforms the market?
Yes,
over the last 12 months INSM made 183.86%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months INSM made -6.73%, while XBI made -9.75%.
Over the last 3 months INSM made -6.73%, while XBI made -9.75%.
Performance Comparison INSM vs Indeces and Sectors
INSM vs. Indices INSM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.19% | 1.34% | 7.90% | 171% |
| US NASDAQ 100 | QQQ | 2.27% | -1.01% | 7.19% | 169% |
| US Dow Jones Industrial 30 | DIA | 3.73% | 3.74% | 8.66% | 175% |
| German DAX 40 | DAX | 3.55% | 1.11% | -10.2% | 159% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.84% | 4.10% | 11.6% | 179% |
| Hongkong Hang Seng | HSI | 3.59% | 2.41% | 7.37% | 171% |
| India NIFTY 50 | INDA | 5.71% | -3.99% | 8.02% | 181% |
| Brasil Bovespa | EWZ | 4.82% | -1.94% | 2.20% | 191% |
INSM vs. Sectors INSM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.04% | 1.49% | 1.92% | 160% |
| Consumer Discretionary | XLY | 3.16% | 1.48% | 6.73% | 169% |
| Consumer Staples | XLP | 5.25% | 1.71% | 3.80% | 173% |
| Energy | XLE | 7.45% | 14.9% | 13.0% | 193% |
| Financial | XLF | 4.30% | 2.90% | 0.97% | 161% |
| Health Care | XLV | 5.89% | 5.56% | 13.1% | 185% |
| Industrial | XLI | 2.87% | 0.59% | 6.86% | 173% |
| Materials | XLB | 5.0% | 4.11% | 15.7% | 188% |
| Real Estate | XLRE | 3.30% | 1.99% | 7.74% | 166% |
| Technology | XLK | 1.63% | -1.54% | 10.9% | 173% |
| Utilities | XLU | 4.47% | 0.79% | 3.48% | 163% |
| Aerospace & Defense | XAR | 2.16% | -6.09% | -5.98% | 156% |
| Biotech | XBI | 3.35% | -4.66% | 23.2% | 189% |
| Homebuilder | XHB | 4.46% | 2.97% | 22.9% | 190% |
| Retail | XRT | 4.43% | 2.05% | 13.9% | 185% |